cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Iqvia Holdings Inc
25 own
20 watching
Current Price
$197.27
$5.75
(3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
43,061.69M
52-Week High
52-Week High
261.73001
52-Week Low
52-Week Low
187.62000
Average Volume
Average Volume
3.35M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
62.9416
iconMarket Capitalization43,061.69M
icon52-Week High261.73001
icon52-Week Low187.62000
iconAverage Volume3.35M
iconDividend Yield--
iconP/E Ratio62.9416
What does the Iqvia Holdings Inc do?
Quintiles IMS Holdings, Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations. This segment also provides OneKey, a reference database of healthcare professionals; real-world insights, and various cloud-based applications and related implementation services; and strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services. The Research & Development Solutions segment offers biopharmaceutical development services comprising project management and clinical monitoring, clinical trial support, and strategic planning and design services, as well as clinical trial, genomic, and bioanalytical laboratory services. The Integrated Engagement Services segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. Quintiles IMS Holdings, Inc. serves pharmaceutical, biotechnology, medical device, and healthcare companies. The company was formerly known as Quintiles Transnational Holdings Inc. and changed its name to Quintiles IMS Holdings, Inc. as a result of its merger with IMS Health Holdings, Inc. in October 2016. The company was founded in 1982 and is headquartered in Durham, North Carolina.
Read More
How much money does Iqvia Holdings Inc make?
News & Events about Iqvia Holdings Inc.
Business Wire
1 year ago
IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, today announced that it has been recognized along with the National Basketball Association and partners at Harvard, Columbia and BioReference...
Business Wire
1 year ago
IQVIA (NYSE:IQV), a global provider of data, analytics, technology solutions and services to the life sciences industry, was recognized as the highest scoring provider in the Leader category of Everest Groups Life Sciences Sales and Marketing Operations PEAK Assessment. This assessment included 17...
Business Wire
1 year ago
IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, today announced that it has been selected as winner of the Best AI-based Solution for Healthcare award in the sixth annual AI Breakthrough Awards, a...
Business Wire
1 year ago
IQVIA (NYSE:IQV) today announced the launch of IQVIA RIM Smart Labeling, a comprehensive labeling solution for the life sciences industry that provides an intelligence-driven approach for more efficient and compliant global label management. Through this unique solution, life sciences companies can...
Zolmax
1 year ago
Kestra Advisory Services LLC lowered its stake in IQVIA Holdings Inc. (NYSE:IQV Get Rating) by 17.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,450 shares of the medical research companys ...
Frequently Asked Questions
Frequently Asked Questions
What is Iqvia Holdings Inc share price today?
plus_minus_icon
Can Indians buy Iqvia Holdings Inc shares?
plus_minus_icon
How can I buy Iqvia Holdings Inc shares from India?
plus_minus_icon
Can Fractional shares of Iqvia Holdings Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Iqvia Holdings Inc stocks?
plus_minus_icon
What is today’s traded volume of Iqvia Holdings Inc?
plus_minus_icon
What is today’s market capitalisation of Iqvia Holdings Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Iqvia Holdings Inc?
plus_minus_icon
What percentage is Iqvia Holdings Inc down from its 52-Week High?
plus_minus_icon
What percentage is Iqvia Holdings Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$197.27
$5.75
(3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
NATIONAL RESEARCH CORP
NATIONAL RESEARCH CORP
$17.17
$0.10 (0.59 %)
agilon health, Inc.
agilon health, Inc.
$1.97
$0.09 (4.79 %)
OptimizeRx Corporation
OptimizeRx Corporation
$4.91
$0.16 (3.37 %)
Twist Bioscience Corp
Twist Bioscience Corp
$47.94
$4.32 (9.90 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
NATIONAL RESEARCH CORP
NATIONAL RESEARCH CORP
$17.17
$0.10 (0.59 %)
agilon health, Inc.
agilon health, Inc.
$1.97
$0.09 (4.79 %)
OptimizeRx Corporation
OptimizeRx Corporation
$4.91
$0.16 (3.37 %)
Twist Bioscience Corp
Twist Bioscience Corp
$47.94
$4.32 (9.90 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00